Evidence-based medicine

Paediatric Respiratory Reviews

Volumn 1, Issue 3, 2000, Pages 287-293

  Smyth, Rosalind L ^a  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Evidence based medicine; Randomised controlled trial; Systematic review

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DECISION SUPPORT SYSTEM; EVIDENCE BASED MEDICINE; HUMAN; LITERATURE; META ANALYSIS; PEDIATRICS; PULMONOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

DECISION SUPPORT TECHNIQUES; EVIDENCE-BASED MEDICINE; HUMANS; META-ANALYSIS; PEDIATRICS; PULMONARY DISEASE (SPECIALTY); RANDOMIZED CONTROLLED TRIALS; REVIEW LITERATURE;

EID: 4544355048     PISSN: 15260550     EISSN: None     Source Type: Journal    
DOI: 10.1053/prrv.2000.0061     Document Type: Conference Paper

References (32)

1. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine; what it is and what it isn't. BMJ 1996; 312: 71-72.
2. Cheng K, Smyth RL, Motley J, O'Hea U, Ashby D. Randomized controlled trials in cystic fibrosis (1966-1997) cateRgorized by time, design, and intervention. Pediatr Pulmonol 2000; 29: 1-7.
3. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. EvidenceBased Medicine: How to Practice and Teach EBM. London: Churchill Livingstone, 1997.
4. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ et al. Assessing the quality of reports of randomized controlled trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
5. Schulz K, Chalmers I, Hayes R, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effect in controlled clinical trials. JAMA 1995; 273: 408-412.
6. Mulrow CD. Rationale for systematic reviews. BMJ 1994; 309: 597-599.
7. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. JAMA 1992; 268: 240-248.
8. Neihouse P, Priske SC. Quotation and accuracy in review articles. DCIP Ann Pharmacother 1989; 23: 594-596.
9. Mulrow CD. The medical review article: state of the science. Ann intern Med 1987; 104:485-488.
10. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991 ; 337: 867-872.
11. Dickersin K. How important is publication bias? A synthesis of available data. AIDS Educ Prev 1997; 9: 15-21.
12. Rennie D. Flanagin A. Publication bias-the triumph of hope over experience. JAMA 2000; 267: 41 1-412.
13. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990; 263: 1385-1389.
14. Dickersin K, Min Y, Meinert C. Factors influencing publication or research results; follow-up of applications submitted to two institutional review boards. JAMA 1992; 263: 374-378.
15. Chalmers I, Adams M, Dickerson K, Hetherington J, Tarnow-Mordi W, Meinert C et al. A cohort study of summary reports of controlled trials. JAMA 1990; 261: 1401-1405.
16. Moher D, Fortin P, Jadad AR, Juni P, Klassen T, Le Lorier J et al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet 1996; 347: 363-366.
17. Linde K, Jobst K, Panton J. Acupuncture for chronic asthma (Cochrane Review). The Cochrane Library, Oxford: Update Software, 2000.
18. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin L et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996; 276: 7-9.
19. Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ 1995; 3 11-485.
20. Cochrane AL. A critical review, with particular reference to the medical profession. In: Teeling-Smith G (ed) Medicines for the Year 2000. London: Office of Health Economics 1979; 1931-1971.
21. Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet 1995; 345: 840-842.
22. Ausejo M, Saenz A, Pham B, Kellner J, Johnson D, Moher D et al. Glucocorticoids for Croup (Cochrane Review). The Cochrane Library, Oxford: Update Software, 2000.
23. Ducharme F. Anti-leukotriene agents and inhaled corticosteroids versus corticosteroids alone for recurrent and/or chronic asthma (Protocol for a Cochrane Review). The Cochrane Library, Oxford: Update Software, 2000.
24. Hicks G, Ducharme FM. Anti-leukotriene agents versus inhaled corticosteroids for recurrent and/or chronic asthma (Protocol for a Cochrane Review). The Cochrane Library, Oxford: Update Software, 2000.
25. Jadad AR, Moher M, Browman G, Sigouin C, Fuentes M, Stevens R. Systematic reviews and meta-analyses on treatment of asthma: critical evaluation. BMJ 2000; 320: 537-540.
26. Yusuf S, Koon T, Woods K. Intravenous magnesium in acute myocardial infarction: an effective, safe, simple and inexpensive interventions. Circulation 1993; 87: 2043-2046.
27. ISIS-4 Collaborative Group. ISIS-4: a randomised factorial trial assessing early captopril, oral mononitrate and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-685.
28. Villar J, Carroli G, Belizan JM. Predictive ability of meta-analyses of randomised controlled trials. Lancet 1995; 345: 772-776.
29. Cappelleri JC, Loannidis JPA, Schmid CH, de Ferranit SD, Aubert M et al. Large trials versus meta-analysis of smaller trials. How to their results compare? JAMA 1996; 276: 1332-1338.
30. LeLorier J, Gregorie G, Benaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomised controlled trials. N Engl J Med 1997; 337: 536-542.
31. Naylor CD. Meta-analysis and the meta-epidemiology of clinical research (editorial). BMJ 1999; 315:617-619.
32. Morgan WKC. Evidence-based medicine. Lancet 1995; 346: 1172.